Loss of Nsmase2 in Breast Cancer progression
by Christopher Clarke, PhD, Department of Medicine
STAT3 as a Critical Determinant of Breast Cancer
by Nancy Reich, PhD, Department of Microbiology
Transcriptome Study of Chemotherapy and PTSD in the CNS
by David McKinnon, Department of Neurobiology and Behavior
Clonal Evolution of Drug Resistance of Breast Cancer Cells
by Scott Powers, Department of Pathology
Deciphering Oncogenic roles of the DNA Damage Transducer RNF8 in Breast Cancer Progression and Chemoresistance
by Chi-Hsin (Lori) Chan, PhD, Department of Pharmacological Sciences
Molecular Characterization of Novel Brk Inhibitors in TNBC
by Markus Seeliger, MD, PhD, Department of Pharmacological Sciences
Cell Cycle Control of Breast Cancer Metastasis In Vivo
by Benjamin L. Martin, PhD and David Q. Matus, PhD,
Departments of Biochemistry and Cell Biology
Role of the Tumor Suppressor Folliculin in Breast Cancer
by Feng-Qian Li, PhD, Department of Pharmacological Sciences
Role of PLD6 in growth of chemoresistant metastases
by Michael Frohman, MD, PhD, Department of Pharmacological Sciences
Development of MRI imaging markers for treatment response early detection and response prediction
by Chuan Huang, PhD, Departments of Radiology and Psychiatry
Development of MRI imaging markers for treatment response early detection and response prediction
by Hyungjin Kim, PhD, Department of Pharmacological Sciences
Translational significance of mutant p53 in Her20positive breast cancer
by Natalia Marchenko, PhD, Department of Pathology
Multifunctional Nanomaterials for Breast Cancer Theranostics
by Kenneth Shroyer, MD, PhD, Department of Pathology
CRISPR screen for functional sensitizers to target mutp53GOF breast cancers
by Ute Moll, MD, MS, Department of Pathology
Mutant p53 metabolically drives metastatic niche formation
by Luis A. Martinez, PhD, Department of Pathology
Pioneering Imaging Technologies for Characterizing Breast Cancer
by Paul Vaska, PhD, Department of Radiology
PET validation of MRI detection of breast cancer metastasis in axillary lymph nodes
by Jules Cohen, MD, Department of Medicine
MRI Detection of axillary lymph node metastasis in breast cancer patients
by Lea Baer, MD, Department of Medical Oncology / Medicine
Imaging metabolic determinants of macrophage infiltration in breast cancer
by Avigdor Leftin, PhD, Department of Radiology
Targeted protein degradation of SMG-1
by Peter Tonge, PhD, Department of Chemistry
Acylceramide, a new resistance mechanism in Breast Cancer
by Daniel Canals, PhD, Department of Medicine
The strategies to overcome PARP inhibitor resistance in TNBCs
by Jun Chung, PhD, Department of Pathology
The role of N2 in Anti-tumor immunity in breast cancer
by Christopher Clarke, PhD, Department of Medicine
Dietary fatty acids effects on breast cancer progression and sphingolipids
by Fabiola Velasquez, PhD, Department of Medicine / Cancer Center
Contrast enhanced mammography for predicting response to neoadjuvant chemotherapy by Alison Stopeck, MD, Department of Medicine
Development of allosteric LATS1 agonists for inhibiting YAP in breast cancer
by Jyoti Misra, PhD, Department of Pharmacological Sciences
Validation of BLVRB as a novel therapeutic target in breast cancer
by Natalie Marchenko, PhD, Department of Pathology
Artificial Intelligence for Personalizing Breast Cancer Screening
by Cindy Lee, MD, Department of Radiology
Single cell analysis of blood brain barrier in response to general anesthetics in brain metastasis of breast cancer
by Jun Lin, MD PhD, Department of Anesthesiology
MDC1 – a new target of therapy-induced senescence and chemo sensitization in breast cancer
by Hyungjin Kim, PhD, Department of Pharmacological Sciences